Skip to search formSkip to main contentSkip to account menu

ingenol mebutate 0.0005 MG/MG Topical Gel

Known as: INGENOL MEBUTATE 0.05% GEL,TOP [VA Product], INGENOL MEBUTATE 0.05% TOP GEL, ingenol mebutate 0.05 % Topical Gel 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
  • J. Ad
  • 2017
  • Corpus ID: 30374782
Actinic keratosis (AK) is a common dermatological disorder on sun-exposed skin. Its premalignant condition is widely known… 
2016
2016
Ingenol mebutate represents a topical treatment for fields with actinic keratosis (AK). The biological effects of ingenol… 
2016
2016
BACKGROUND Epidermodysplasia verruciformis (EV) is a rare genetic disorder characterized by widespread human papillomavirus (HPV… 
2016
2016
Actinic keratosis (AK) is a cutaneous intraepithelialneoplasma appearing within areas referred as ‘fields of cancerization’caused… 
2015
2015
Actinic keratoses (AKs) are premalignant skin lesions caused by cumulative ultraviolet-light exposure that may progress to… 
2015
2015
92 Abstract. – OBJECTIVE: Cumulative exposure of the skin to ultraviolet radiation promotes mutation in keratinocytes and their… 
2012
2012
Ingenol mebutate topical gel (0.015% for face and scalp and 0.05% for trunk and extremities) was effective for treating actinic… 
2012
2012
Ingenol mebutate topical gel (0.015% for face and scalp and 0.05% for trunk and extremities) was effective for treating actinic… 
2009
2009
Preliminary pilot studies (see JW Dermatol Feb 27 2009) indicated that ingenol mebutate might be effective for treating actinic…